AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On August 29, 2025,
(CLX) traded with a volume of $0.21 billion, a 20.04% decline from the prior day, ranking 436th in market activity. The stock closed at $118.20, reflecting modest gains amid mixed analyst sentiment and shifting institutional holdings.Clorox reported robust quarterly earnings, exceeding expectations with $2.87 per share (EPS) and $1.99 billion in revenue, a 4.5% year-over-year increase. The company also raised its quarterly dividend to $1.24 per share, yielding 4.2%, while maintaining a payout ratio of 76.07%. Despite these positives, analysts have downgraded the stock, with a "Reduce" consensus rating and an average price target of $143.36.
Institutional investors adjusted positions in CLX during the first quarter. Champlain Investment Partners reduced its stake by 7.6%, while FORA Capital acquired 13,620 shares. Other firms, including GW&K Investment Management and Roble Belko & Company, increased holdings. Institutional ownership remains at 78.53% of the float.
Clorox’s return on capital employed (ROCE) of 33% outperforms the industry average of 23%, driven by a 25% five-year growth. However, current liabilities now account for 35% of total assets, signaling potential efficiency risks. The stock’s beta of 0.49 highlights its low volatility relative to the broader market.

Hunt down the stocks with explosive trading volume.

Dec.29 2025

Dec.29 2025

Dec.29 2025

Dec.29 2025

Dec.29 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet